Websites linking back to regeneron.com

Discover PRALUENT® (alirocumab) for adults with uncontrolled bad cholesterol who have heart problems due to plaque build-up in arteries or HeFH.

Non-profit solution to senior transportation and people with visual impairments. The ITN is a sustainable, community-based transportation service for seniors.

Advocating Angiogenesis-based medicine, diets, and lifestyle.

Find Health Care Professional focused information about PRALUENT® (alirocumab), for patients with poorly controlled LDL-C and HeFH or clinical ASCVD.

Learn about DUPIXENT®, a new treatment for adults with uncontrolled moderate-to-severe eczema (atopic dermatitis). See Important Safety Information, indication and patient information.

Learn about high LDL cholesterol and watch a documentary sharing true stories of those living with the condition.

DUPIXENT® is for your adult patients with uncontrolled moderate-to-severe atopic dermatitis. Learn more now. Please see Prescribing Information and Important Safety Information on website.

EYLEA is an FDA-approved medication that’s administered by an injection into the eye to treat certain retina diseases. See safety and risk information.

Informazione indipendente e specializzata sugli affari della Unione Europea. Il portale italiano del network editoriale EurActiv con notizie, interviste, articoli e approfondimenti sulle politiche dell'Italia e dell'Europa.

Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need.

Elevated IL-6 plays an important role in RA. Learn about articular and systemic effects of persistently elevated IL-6 levels in RA patients.

Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need.

MedTech

ITNGateway provides a transportation solution for seniors and the visually impaired. Helping seniors keep their independence through an affordable transportation.